Contemporary approaches to the treatment of arterial hypertension and ischemic heart disease

被引：0
|
作者：
Sorokin, E. V. [1 ]
机构：
[1] AL Myasnikov Inst Clin Cardiol, Moscow 121552, Russia
来源：
KARDIOLOGIYA | 2006年 / 46卷 / 04期
关键词：
hypertension; ischemic heart disease; treatment; prognosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prognostic advantage of a combination of calcium antagonist and angiotensin converting inhibitor (ACEI) over combination of beta-adrenoblocker with tiazide diuretic was proved in a large randomized study of long term treatment of arterial hypertension. in another randomized study administration of ACEI for 12 months caused substantial retardation of cardiac remodeling in elderly patients with normal left ventricular function in postinfarction period. These results are important for a practical physicians as they concern treatment of wide circle of in- out-patients.
引用
收藏
页码：81 / 84
页数：4
相关论文
共 50 条
  • [11] Pharmacokinetic studies of Cardil in patients with ischemic heart disease and arterial hypertension
    Ivanovskaya E.A.
    Gusakova A.M.
    Vovchenko I.A.
    Teplyakov A.T.
    Pharmaceutical Chemistry Journal, 2000, 34 (11) : 573 - 574
  • [12] Hypertension and ischemic heart disease
    Spinar, Jindrich
    COR ET VASA, 2012, 54 (06) : E433 - E438
  • [13] PARENTAL HISTORY OF ARTERIAL HYPERTENSION AND ARTERIAL PRESSURE IN CHILDREN OF PERSONS WITH EARLY ISCHEMIC HEART DISEASE
    Konnov, M. V.
    ATHEROSCLEROSIS, 2021, 331 : E146 - E147
  • [14] Metabolic approaches to the treatment of ischemic heart disease: The clinicians' perspective
    Wolff A.A.
    Rotmensch H.H.
    Stanley W.C.
    Ferrari R.
    Heart Failure Reviews, 2002, 7 (2) : 187 - 203
  • [15] New Rational Therapy of Metabolic Syndrome in Ischemic Heart Disease and Arterial Hypertension
    Chikovani, Nino M.
    Bochorishvili, Tamar M.
    Rogava, Mamanti A.
    Danelia, Vadim Sh.
    Tsivtsivadze, Edisher T.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 : 71 - 72
  • [16] Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease
    Gonzalez, Azuah L.
    Dungan, Matthew M.
    Smart, C. Duncan
    Madhur, Meena S.
    Doran, Amanda C.
    ANTIOXIDANTS & REDOX SIGNALING, 2024, 40 (4-6) : 292 - 316
  • [17] EXPERIENCE OF USING VISKEN IN ISCHEMIC HEART-DISEASE AND ARTERIAL (ESSENTIAL) HYPERTENSION
    KOMAROV, FI
    KUN, IS
    MARKOVA, VM
    MYTAREVA, IL
    OSTROVSKAYA, VI
    SOVETSKAYA MEDITSINA, 1977, (01): : 53 - 55
  • [18] THE EFFECT OF TREATMENT OF HYPERTENSION ON ISCHEMIC-HEART-DISEASE - A REVIEW
    WIDIMSKY, J
    COR ET VASA, 1986, 28 (01) : 1 - 7
  • [19] THE STUDY OF MYOCARDIUM REMODELING AFTER INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
    Dedov, D. V.
    Masyukov, S. A.
    Yevtyukhin, I. Y.
    Kovalchuk, A. N.
    Asisova, M.
    Yarakhmedova, T.
    ARCHIV EUROMEDICA, 2015, 5 (01): : 55 - 57
  • [20] The use of reductal in the treatment of patients with arterial hypertension and ischemic heart disease associated with type 2 diabetes mellitus
    Karpov, R. S.
    Koshel'skaya, O. A.
    Chernov, V., I
    DIABETES MELLITUS, 2006, 9 (01): : 28 - 32
12345